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Abstract
The liver endothelium plays a key role in the progression and resolution of liver diseases in young and adult individuals. However, its role 
in older people remains unknown. We have herein evaluated the importance of the sinusoidal endothelium in the pathophysiology of acute 
liver injury, and investigated the applicability of simvastatin, in aged animals. Eighteen-months-old male Wistar rats underwent 60 minutes of 
partial warm ischemia followed by 2 hours of reperfusion (WIR). A group of aged rats received simvastatin for 3 days before WIR. Endothelial 
phenotype, parenchymal injury, oxidative and nitrosative stress, and fenestrae dynamics were analyzed. The effects of WIR and simvastatin 
were investigated in primary LSEC from aged animals. The results of this study demonstrated that WIR significantly damages the liver 
endothelium and its effects are markedly worse in old animals. WIR-aged livers exhibited reduced vasodilation and sinusoidal capillarization, 
associated with liver damage and cellular stress. Simvastatin prevented the detrimental effects of WIR in aged livers. In conclusion, the liver 
sinusoidal endothelium of old animals is highly vulnerable to acute insult, thus targeted protection is especially relevant in preventing liver 
damage. Simvastatin represents a useful therapeutic strategy in aging.
Keywords: Liver sinusoidal endothelial cells, LSEC, Hepatic hemodynamic, Intrahepatic vascular resistance, Statins
Ischemia/reperfusion injury is caused by an initial interruption of 
blood supply, followed by the restoration of perfusion. The impact 
of the cessation and reestablishment of blood supply can result in 
a cascade of pathological impacts, such as oxidative stress, release 
of prothrombotic cytokines and apoptosis (1). Clinically, warm 
ischemia-reperfusion (WIR) injury is almost unavoidable in liver 
resection surgery, transplantation, and in blood transfusion after 
hemorrhagic shock, and may contribute to delayed graft function 
and liver failure. In addition to the well-defined parenchymal injury 
(2,3), we recently demonstrated that ischemia reperfusion causes an 
acute deterioration of the hepatic microvascular function both in 
cold and warm ischemia conditions (4–6).
In accordance with the current population pyramids, most of the 
clinical situations involving hepatic WIR occur in people aged more 
than 60 and, although we have not yet fully elucidated the mechan-
isms it has been previously shown that older livers are more suscep-
tible to pathological stress responses, have decreased regenerative 
capacity, and this results in increased morbidity and mortality (7–
12). A key factor in our limited understanding of the mechanisms 
involved in the age-related loss of resilience to ischemia-reperfusion 
Copyedited by: NI
D
ow
nloaded from
 https://academ
ic.oup.com
/biom
edgerontology/advance-article-abstract/doi/10.1093/gerona/glz012/5289188 by U
niversitaetsbibliothek Bern user on 20 D
ecem
ber 2019
s
o
u
r
c
e
:
 
ht
tp
s:
//
do
i.
or
g/
10
.7
89
2/
bo
ri
s.
13
72
96
 
| 
do
wn
lo
ad
ed
: 
27
.1
.2
02
0
injury may be that the majority of the present understanding derives 
from experiments conducted in young animals (aging 6–16 weeks) 
with only very few studies evaluating the effects of acute liver injury 
in older livers (13,14). The initial point of impact of ischemia-reper-
fusion injury in the liver is the liver sinusoid, a highly differentiated 
and specialized vascular bed. Lining these vessels are the liver sinus-
oidal endothelial cells (LSEC), which have major physiological roles 
in homeostasis, immune function, and facilitating bi-directional 
transfer of substances between blood and the space of Disse via 
fenestrations (15–18). With aging, significant ultrastructural and 
functional changes in LSEC are produced conducing to a phenom-
enon termed pseudo-capillarization (19,20). Importantly, a recently 
published study from our group deeply characterized the hepatic 
sinusoid in aging demonstrating that healthy aged livers exhibit 
slight but significant de-regulation in hepatic and microcirculatory 
functions, which may result in a higher vulnerability in the face of 
acute injury (21).
Statins, HMG-CoA inhibitors designed to lower cholesterol 
levels, have many pleiotropic effects independent of lipid lowering 
(22). Administration of simvastatin, one of the most widely evalu-
ated statins, has demonstrated its effectiveness protecting the liver 
sinusoidal endothelium in experimental models of chronic and acute 
liver injury in young animals (4,6,23–25). However, it’s utility in 
acute liver injury in older is completely unknown.
This study was designed to better understand the effects of 
acute liver injury on aged rats, in particular focusing on sinusoidal 
endothelial phenotype and liver ultrastructure; and to further inves-
tigate the applicability of statins preventing liver injury in aging.
Methods
Animals and Treatment
Male Wistar rats aging 18 months (Janvier Laboratories, Le Genest-
Saint-Isle, France) were treated with simvastatin (25  mg/kg body 
weight) or its vehicle by gavage once a day for 3 days. Dosing of 
statin was based on previous literature from our team and others 
(23,25,26). Animals were kept in environmentally controlled animal 
facilities at the Institut d’Investigacions Biomèdiques August Pi i 
Sunyer (IDIBAPS). All experiments were approved by the Laboratory 
Animal Care and Use Committee of the University of Barcelona and 
were conducted in accordance with European Community guide-
lines for the protection of animals used for experimental or other 
scientific purposes (EEC Directive 86/609).
Liver Vascular Studies
Under anesthesia with intraperitoneal ketamine (100 mg/kg, Merial 
Laboratories, Barcelona, Spain) and midazolam (5 mg/kg, Normon, 
Tres Cantos, Madrid, Spain) partial warm ischemia affecting 70% 
of liver volume was induced by clamping the portal triad irrigating 
the medial and left lateral lobes with an atraumatic clamp for 1 hour, 
which was followed by 2 hours of reperfusion (27). Sham operated 
animals were included. After the WIR period, liver microvascular 
response was assessed in the isolated, in situ liver perfusion system, 
as described (28). Livers were perfused at a constant portal flow of 
35 mL/min and after 20 minutes of stabilization, liver endothelial 
function was evaluated analyzing endothelium-dependent vasore-
laxation to incremental doses of acetylcholine (Ach; 10−7 to 10−5 M) 
after pre-constriction with methoxamine (10−4 M).
At the end of the study, liver samples from lobules that suffered 
WIR were stored for molecular analysis as described below.
Electron Microscopy
After the experimental procedure, 5–7 livers per group were perfused 
through portal vein with a fixation solution containing 2.5% glu-
taraldehyde and 2% paraformaldehyde in 0.1 M cacodylate buffer 
0.1% sucrose and fixed overnight at 4°C. Samples were washed 
three times with 0.1 M sodium cacodylate buffer. Liver sections were 
post-fixed with 1% osmium in cacodylate buffer and dehydrated in 
an ethanol or acetone gradient to 100%.
For scanning electron microscopy 6–8 liver blocks per sample 
were mounted on stubs, sputter coated with platinum and examined 
using a Jeol 6380 scanning electron microscope (JEOL Ltd, Tokyo, 
Japan). At least 10 images per animal were taken.
Measurements of fenestrae size, number, and density were car-
ried out. Fenestrations were defined as open pores with diameters 
<300 nm. Diameter was defined as the major length of each fenestra-
tion or gap. Porosity was defined as the sum area of fenestrations/
total quantified area. Frequency was defined as number of fenestrae 
per μm2 (29).
For transmission electron microscopy, fixed liver tissue 
was embedded in Spurr resin, cut in 50  nm ultrathin sections, 
counterstained with uranyl acetate and lead citrate and exam-
ined using Philips CM10 transmission electron microscope. Ten 
micrographs per sample were taken to estimate % of necrotic 
hepatocytes and % of sinusoids presenting each of the evaluated 
parameters (21).
Histological Analysis
Liver samples were fixed in 10% formalin, embedded in paraf-
fin, sectioned, and slides were stained with hematoxylin and eosin 
(H&E) to analyze the hepatic parenchyma (30). Hepatic histology 
was scored by two blinded independent researchers as previously 
described (31). Briefly, cytoplasmic vacuolation, nuclear pyknosis, 
cytoplasmic hypereosinophilia, loss of intercellular borders, necrosis 
and fat accumulation were scored as 0—abstent, 1—focal, or 2—
general, and neutrophil infiltration as 0—absent or 1—present, mak-
ing a maximum final score of 13 points.
Immunohistochemical Stainings
Liver samples were fixed in 10% formalin, embedded in paraffin 
and sectioned. After antigen retrieval procedure and endogenous 
peroxidase activity inhibition, sections were incubated with anti-
von Willebrand Factor (1:400; Dako, Glostrup, Denmark), anti-a-
SMA (1:1,000; M0851, Dako), anti-CD68 (1:100; BioRad, Paris, 
France) or anti-CD163 (1:100; BioRad) 1 hour at room tempera-
ture. HRP-Rabbit/Mouse (Dako) secondary antibody was added. 
Color development was induced by incubation with a DAB kit 
(Dako) and the sections were counterstained with hematoxylin. 
Sections were dehydrated and mounted. The specific staining was 
visualized and images were acquired using a microscope equipped 
with a digital camera and the assistance of Axiovision software. 
vWF relative volume was determined by point-counting morpho-
metry on immunoperoxidase-stained sections, using a point grid to 
obtain the number of intercepts over vWF positive cells over the 
tissue. Six fields per liver were counted and the relative volume was 
calculated by dividing the number of points positive in sinusoidal 
areas by the total number of points over liver tissue (6). For CD68 
and CD163, 10 images per sample were obtained and positive cells 
per field were counted. All analyses were performed blindly by two 
independent researchers.
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Nitric Oxide Determination
Levels of cGMP, surrogate marker of NO bioavailability, were ana-
lyzed in liver homogenates using an enzyme immunoassay following 
manufacturer instructions (Cayman Chemical Co., Ann Arbor, MI) (4).
Nitrotyrosine Fluorohistochemistry
Quantitative tyrosine nitration detection was performed as previ-
ously described (5). Briefly, slides were deparaffinised, hydrated, incu-
bated with aqueous sodium dithionite solution (10 mM) for 10 min, 
washed with distilled water and then incubated overnight at 4°C 
with an equimolar solution of AlCl3 and salicylaldehyde (200 mM). 
Afterwards, the aqueous solution was removed and sections were 
mounted in Fluoromount G medium (Southern Biotech, Birmingham, 
AL). Negative controls were included. Fluorescence images were 
obtained with a fluorescence microscope and quantitative analysis 
of at least six images per sample was performed with Image J 1.44m 
software (National Institutes of Health, Bethesda, MD).
Real-Time Quantitative PCR
RNA from liver tissue was extracted using Trizol (Life Technologies), 
quantified using Nanodrop software (ND1000, Marshall 
Scientific, Hampton, NH) and reverse transcribed to cDNA using 
Quantitect Reverse Transcription Kit (205311, Qiagen) previ-
ous elimination of genomic DNA of the sample. cDNA tem-
plates were amplified by SYBR green using the following primers 
(a-SMA: F, CTCATGCCATCATGCGTCTG; R, CACGCTCAG 
CAGTAGTCACG; Col1a1: F, GTACATCAGCCCAAACCCCA; 
R, TCGCTTCCATACTCGAACTGG; Col1a2: F, TCGCTTCCAT 
ACTCGAACTGG; R, GATGGCCTTTCTCACCAGGTT; pdg-
frb: F, GTCAATGTCCCTGTCCGTGT; R, GTGTGGGTGACAG 
TTTTCGC; desmin: F, CAACTTCCGAGAAACCAGCC; R, 
CGTGTCTGGCTTACAGCACT; tnfa: F, ATGGGCTCCCT 
CTCATCAGT; R, GCTTGGTGGTTTGCTACGAC; il6: F, 
TCCGGAGAGGAGACTTCACA; R, GCCATTGCACAACT 
CTTTTCT; gapdh: F, GGCATCGTGGAAGGGCTCAT; R, 
AGGGATGATGTTCTGGGCTGC). Ct values were normalized to 
those of GAPDH and expressed as relative changes versus the con-
trol (ΔΔCt method). All PCR reactions were performed in duplicate 
and using nuclease‐free water as controls.
Liver Sinusoidal Endothelial Cells Isolation and 
Treatments
Rat liver sinusoidal endothelial cells (LSEC) were isolated by col-
lagenase perfusion and Percoll density gradient as described (28). 
Highly pure and viable cells were used.
After 2 hours of isolation, LSEC were washed with phosphate-
buffered saline (PBS) and treated with simvastatin (1  µM) or its 
vehicle (DMSO 0.1%) for 1 hour. After the treatment LSEC were 
incubated for 1 hour in an anoxic chamber (BD GasPak, BD Life 
Sciences), and afterwards removed from the chamber and immedi-
ately placed in the cell-culture incubator for reoxygenation during 
2 hours.
Cells were processed for in situ analysis of intracellular levels of 
superoxide (O2
−) and nitric oxide (NO), or for SEM, as described 
below.
LSEC Electron Microscopy
Scanning electron microscopy on the cultured LSEC was per-
formed as described (29). After the experimental procedure, LSEC 
were fixed in 2.5% glutaraldehyde in a 0.1 M sodium cacodylate 
buffer. Cells on coverslips were osmicated (1% OsO4 in 0.1 M 
cacodylate buffer), dehydrated in an ethanol gradient to 100% and 
incubated for 2 minutes in hexamethyldisilazane. Coverslips were 
mounted on stubs, sputter coated with gold and examined using a 
Jeol 6380 scanning electron microscope (JEOL Ltd, Tokyo, Japan).
LSEC Actin Filament Staining
Actin filament structures were stained in primary LSEC with the 
Phalloidin Fluorescein Isothiocyanate Labelled (P582, Sigma–
Aldrich) as described (32). Briefly, LSEC were fixed for 10 minutes 
in 4% paraformaldehyde in PBS, permeabilized for 10 minutes with 
0.1% TRITON X-100 and stained with a 50  µg/mL fluorescent 
phalloidin conjugate solution for 30 minutes at 37°C. LSEC were 
visualized using a Leica DM2500 Confocal Microscope (Leica Ltd, 
Wetzlar, Germany) and cellular cytoskeleton organization was evalu-
ated qualitatively.
DHE and DAF Staining
In situ O2
− and NO levels in LSEC were assessed with the fluores-
cent dyes dihydroethidium (DHE 10 µM; Molecular Probes, Inc., 
Eugene, OR) or 4-amino-5-methylamino-2′,7′-difluorofluorescein 
diacetate (DAF-FM-DA 10 µM; Molecular Probes, Inc.) respectively 
as described (33,34). Fluorescence images were obtained with a fluo-
rescence microscope (Olympus BX51, Tokyo, Japan), and quantita-
tive analysis of at least 20 images per condition was performed with 
Image J 1.44m software.
Western Blotting
Liver samples were processed and western blot performed as 
described (28). Used primary antibodies: Nrf2 (Santa Cruz Biotech, 
Santa Cruz, CA), HO-1 (Enzo Life Sciences, Farmingdale, NY), 
phosphorylated eNOS at Ser1177 (Cell Signaling, Danvers, MA), 
total eNOS (BD Transduction Laboratories, Lexington, KY), 
VEGF (Abcam, Cambridge, UK), Flk1 (Santa Cruz Biotech, Santa 
Cruz, CA), phosphorylated myosin light chain at Ser19 (p-MLC, 
Cell Signaling) and phosphorylated moesin at Thr558 (Santa Cruz 
Biotech) all 1:1,000. Blots were revealed by chemiluminescence and 
protein expression was determined by densitometric analysis using 
the Science Lab 2001 Image Gauge (Fuji Photo Film, Düsseldorf, 
Germany). Blots were also assayed for GAPDH (1:5,000, Sigma–
Aldrich) content as standardization of sample loading.
Statistical Analysis
Statistical analyses were performed with the IBM SPSS Statistics 20 
for Windows statistical package. All results are expressed as mean 
± standard error of the mean. Comparisons between groups were 
performed with analysis of variance followed by LSD post hoc test, 
Student’s t test or nonparametrical tests when adequate. Differences 
were considered significant at p < .05.
Results
Effects of WIR on Microcirculatory Phenotype and 
Function in Old Livers
Liver warm ischemia followed by a 2-hour-reperfusion period 
promoted the development of microvascular dysfunction in old 
animals as evidenced by their reduced response to the endothelial-
dependent vasodilator acetylcholine (Figure 1A). Importantly, old 
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livers undergoing acute injury exhibited significantly worse impair-
ment in microvascular function compared with young animals 
(6). This microvascular dysfunction in older rats was further con-
firmed by a fourfold increase in the sinusoidal expression of vWF, 
a well-accepted marker of LSEC capillarization (Figure 1B, top). 
Histological examination revealed that livers from older rats that 
had undergone WIR had significant hepatocellular damage includ-
ing cytoplasmic vacuolization, neutrophil infiltration, and necrotic 
hepatocytes (Figure 1B, bottom). Biochemical analyses further dem-
onstrated WIR-derived liver damage; while AST and ALT levels 
where 88 and 65 UI/mL in blood from sham animals these values 
raised to 2,420 and 4,669 UI/mL, respectively, in the WIR group. 
Liver ultrastructure characterization using transmission electron 
microscopy confirmed that WIR caused loss of hepatic microvilli, 
enlargement of the Space of Disse, gap formation in the endothe-
lium, peliosis (red blood cells in the space of Disse or parenchyma) 
and hepatocyte necrosis (Figure 1C).
Old rats that underwent pretreatment with simvastatin for 
3  days exhibited attenuated WIR-associated microcirculatory 
derangements as indicated by improved sinusoidal function and 
vWF sinusoidal expression (Figure 1A and B). Furthermore, simvas-
tatin treatment before WIR significantly reduced the hepatocellular 
damage observed by histological and ultrastructural examination 
(Figure 1B and C) but was not able to normalize liver enzymes (AST: 
2,216 UI/mL, ALT: 5,926 UI/mL).
De-regulation of Oxidative and Nitrosative Stress in 
Aged Livers Undergoing WIR
WIR promoted a dramatic de-regulation in the intrahepatic oxida-
tive and nitrosative stress. Indeed, acute liver injury led to an incre-
ment in intrahepatic NO, as suggested by the raise in the levels of 
its surrogate marker cGMP (Figure 2A), which was accompanied 
by higher nitrotyrosine formation, indicative of increased peroxyni-
trite production (Figure 2B), and reduced levels of the antioxidant 
transcription factor Nrf2 (Figure 2C). These changes were associated 
with a reduction in the expression of the active form of endothelial 
nitric oxide synthase (eNOS) (Figure 2D).
Simvastatin prevented the increments in NO and nitrotyrosines 
(Figure 2A and B), maintained the expression of Nrf2 and poten-
tiated the antioxidant enzyme HO-1 (Figure 2C and E), while no 
changes in p-eNOS were observed (Figure 2D).
Nitric oxide and oxidative stress were also evaluated in LSEC 
isolated from vehicle- or simvastatin-treated aged rats undergoing 
in vitro anoxia and reoxygenation. We observed that O2
− levels were 
reduced in the simvastatin-treated group (Figure 2F), thus confirm-
ing what was observed in liver tissue. Interestingly, LSEC from the 
simvastatin-treated group exhibited increased NO levels compared 
with vehicle cells (Figure 2G), suggesting an improvement in intra-
cellular endothelial NO availability.
Characterization of Sinusoidal Cells Phenotype in 
Aged Livers Undergoing WIR
Scanning electron microscopy (SEM) analysis of liver tissue and pri-
mary cultured LSEC revealed that acute liver injury causes a signifi-
cant reduction in fenestrae frequency, without changes in diameter, 
which conduces to a reduced porosity (the % of area covered by 
fenestrae) (Figure 3A and B). The beneficial effects of simvastatin on 
endothelial phenotype of 18-month-old livers following WIR was 
further supported by the observed maintenance of fenestrae number 
and endothelial porosity (Figure 3A and B).
Interestingly, maintenance of LSEC fenestrae in response to simv-
astatin was accompanied by reorganization of cellular cytoskeleton, 
as suggested by actin staining (Figure 3C). While vehicle-treated 
cells from WIR exposed livers exhibited an accumulation of abnor-
mal cortical actin structures, which looked like small crescents or 
aggregates, LSEC treated with simvastatin maintained an organized 
cytoskeleton.
Due to the impact of the vascular endothelial growth factor 
(VEGF) on actin filament organization (35), this pathway was evalu-
ated in liver tissue for the potential role in the fenestrae changes 
observed here. As seen in Figure 3D, hepatic VEGF protein expres-
sion was increased in simvastatin-treated aged animals, while its 
receptor Flk-1 was significantly reduced (Figure 3E). An additional 
mechanism for fenestrae regulation, namely contraction of actin 
cytoskeleton via rho-kinase (36), was also evaluated by p-MLC and 
p-moesin protein determination in liver tissue, but there were no dif-
ferences between both groups undergoing WIR (data not shown).
Analysis of hepatic stellate cells (HSC) and hepatic macrophages 
(HMΦ) phenotype was performed by evaluating the protein and 
mRNA expression of specific markers in liver tissue. The results did 
not evidence any effect of simvastatin treatment on HSC pheno-
type (no changes in a-SMA, collagen 1a1, collagen 1a2, pdgfrb and 
desmin; data not shown). Contrarily, when analyzing the changes 
suffered by HMΦ, we observed a change in morphology from spin-
dle to oval shaped and a trend to increased CD163 positive cells in 
vehicle+WIR compared with sham animals (Supplementary Figure 
1A). Simvastatin preserved the spindle-like morphology in some of 
the individuals and prevented the increase in CD163 positive cells. 
At mRNA level, TNFα expression was reduced in simvastatin-
treated animals without changes in IL-6 (Supplementary Figure 1B).
Discussion
Chronological age represents one of the most significant risk fac-
tors for the development of many diseases, such as liver disease, car-
diovascular disease, and diabetes. It is now widely understood that 
intervention in the pathways involved in aging may have significant 
impact on the prevention of these age related conditions.
A recent study from our group described that healthy aging is 
associated with mild hepatic microcirculatory dysfunction, endothe-
lial de-differentiation and a moderate activation of hepatic stel-
late cells (21). This study indicated that even if those changes are 
asymptomatic, the livers of older individuals may have less protec-
tive mechanisms against liver injury compared with young individu-
als. To further explore this hypothesis, we performed the present 
study evaluating the effects of an acute liver injury, as can be warm 
ischemia/reperfusion, in aged animals and proposed a vasoprotective 
strategy for this specific subpopulation.
The first observation derived from our study is that even if there 
is not a significant difference in liver endothelial function com-
paring sham-operated young and old animals, the effects of WIR 
on liver microcirculatory function is markedly worse in the aged 
ones. Indeed, our previous results studying hepatic WIR in young 
animals evidenced the development of acute circulatory dysfunction 
after 1 hour of warm ischemia followed by 2 hours of reperfusion 
(6). However, we herein show that applying the same experimental 
procedure to 18-month-old rats causes much more severe micro-
circulatory dysfunction determined by the reduced response to the 
vasodilator acetylcholine, which is accompanied by increased sinus-
oidal vWF expression. In addition, histological and ultrastructural 
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Figure 1. Warm ischemia and reperfusion markedly deteriorates liver microcirculation and hepatic viability in aged animals. (A) Evaluation of liver microcirculatory 
function as response to incremental doses of acetylcholine in aged animals treated with simvastatin, or vehicle, undergoing 1 hour of 70% hepatic warm 
ischemia followed by 2 hours of reperfusion, or sham-operation. (B) Sinusoidal vWF protein expression (top), and H&E staining and semi-quantitative analysis 
of liver damage (bottom) in aged livers described in A. Representative images ×20. (C) Top: transmission electron micrographs of aged rats described in A 
(original magnification ×1,700 and ×6,000; arrowhead: lack of microvilli, double-headed arrow: enlarged space of Disse, asterisk: gaps in endothelium, arrow: 
peliosis, n: necrotic hepatocytes). Bottom table: % of total sinusoids presenting each of the evaluated parameters. Values represent mean ± standard deviation; 
n = 8 animals per group (A and B), n = 3 animals per group (C); *p < .05 vs sham, #p < .05 vs vehicle; PPP = portal perfusion pressure.
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analysis revealed that WIR caused significant liver damage, both in 
liver sinusoids and parenchymal cells.
Statins exert cholesterol-independent hepatoprotective beneficial 
effects in preclinical and clinical scenarios of liver diseases, such as 
cirrhosis and bacterial infection (23,25,37–39). Nevertheless, very 
little is known about the effects of statins in older animal models. 
In fact, a single experimental study evaluated the effects of simvas-
tatin in livers from healthy aged rats (40), showing positive impacts 
Figure 2. Warm ischemia and reperfusion de-regulates the oxidative stress and nitric oxide pathways in aged livers. (A) cGMP levels in liver tissue from aged rats 
pretreated with simvastatin, or vehicle, undergoing 1 hour of partial ischemia followed by 2 hours of reperfusion, or sham operation. (B) Nitrotyrosinated proteins 
fluorohistochemistry from livers described in A. (C) Representative images of Nrf2 and its corresponding densitometric analysis normalized to GAPDH from 
livers described in A. Results are referred to sham group. (D) Representative western blots of phosphorylated eNOS (p-eNOS) and total eNOS and corresponding 
quantification. (E) Representative western blots of heme oxygenase-1 (HO-1) and corresponding quantification. (F) Endothelial oxidative stress assessed as 
superoxide radical levels (O2
−,) determined in primary LSEC pretreated with simvastatin or vehicle and cultured under anoxia/reoxygenation conditions. Fluorescent 
intensity was divided by total number of cultured cells. (G) Endothelial nitric oxide (NO) levels from cells described in F. Fluorescent intensity was divided by total 
number of cultured cells. Representative images ×20; n = 8 animals per group (A–E), n = 3 animals per group (F–G); *p < .05 vs sham, #p < .05 vs vehicle).
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Figure 3. De-differentiation of the liver sinusoidal endothelium of aged livers suffering acute warm ischemia and reperfusion injury. (A) Liver tissue scanning 
electron micrographs from WIR-aged animals pretreated with simvastatin, or vehicle, or animals sham operated. Top: illustrative images representing the 
luminal surface of liver sinusoidal endothelial cells (original magnification ×15,000). Bottom: fenestration frequency, porosity and diameter quantification. 
(B) Representative scanning electron micrographs of vehicle or simvastatin-treated LSEC undergoing anoxia/reoxygenation and quantification (original 
magnification ×5,000). (C) Representative images of actin filament staining of cells described in B (×63). (D) Representative images of hepatic VEGF immunoblots 
and densitometric analysis normalized to GAPDH from livers described in A. (E) Representative images of Flk-1 western blot and its corresponding quantification 
from livers described in A. n = 5 animals per group (A, B, and C), n = 8 animals per group (D–E); *p < .05 vs sham, #p < .05 vs vehicle).
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on liver function after treatment. Considering the vasoprotective ef-
fects of statins in young animals, we studied the effects of a 3-day 
pretreatment with simvastatin on liver endothelial function during 
WIR. Our results demonstrate that simvastatin diminishes the de-
velopment of hepatic microcirculatory dysfunction in front of an 
acute injury in aged animals, which is accompanied by reduced par-
enchymal damage. We hypothesize that the beneficial effects of sim-
vastatin on liver parenchyma are due to paracrine signals from the 
better-preserved sinusoids (41), although direct effects of the drug on 
hepatocytes cannot be discarded.
To unravel the underlying mechanisms causing WIR damage 
in aged livers we evaluated the NO pathway and ROS produc-
tion as two main components regulating the hepatic microcircula-
tion (42,43). Our results reflect a burst in hepatic NO levels due to 
WIR that is accompanied by marked protein nitrotyrosination. Such 
increment in NO may be rarely due to a physiological NO produc-
tion by eNOS, but to iNOS production. Indeed, it has been described 
that iNOS-derived NO results cytotoxic through the generation of 
reactive nitrogen species (RNS), promotion of proinflammatory 
cytokines, chemokines release, and leukocyte activation (44–47). 
We therefore analyzed the main enzymes contributing to hepatic 
NO generation and determined no change in iNOS expression but 
a significant reduction in phosphorylated eNOS in WIR-aged livers. 
Altogether suggesting that increased iNOS activity upon reperfusion 
is the main cause of NO boost, which will then result in ROS and 
RNS formation. While the role of the transcription factor Nrf2 was 
not conclusively shown, it would be interesting to follow up the role 
of this transcription factor in reducing the antioxidant capacity of 
those livers and how this may contribute to the increased oxidative 
stress observed.
Importantly, administration of simvastatin to aged rats was effec-
tive preventing the WIR-derived pathological increase in NO and 
protein nitrotyrosination, without modifying eNOS phosphoryla-
tion. The reduction in ROS formation was accompanied by a signifi-
cant increase in hepatic Nrf2 protein expression and its target gene 
HO-1. These observations were complemented by the analysis of the 
specific phenotype of LSEC isolated from vehicle- or simvastatin-
treated aged animals that were then subjected to anoxia/reoxygena-
tion in vitro mimicking in vivo WIR. The results support the data 
from liver tissue pointing to reduced WIR-derived ROS in LSEC 
from simvastatin-treated animals. Interestingly, these in vitro experi-
ments revealed a trend of higher NO levels in endothelial cells from 
the simvastatin group, which may not be possible to observe when 
analyzing whole liver homogenates.
Finally, and as gold standard technique to evaluate the sinus-
oidal phenotype, we performed scanning electron microscopy in 
liver tissue and primary LSEC from the three experimental groups 
included in this study. Sham-operated animals had fenestrae fre-
quency and porosity comparable to previous data (48), thus discard-
ing microvascular injury due to animal manipulation. However, it is 
important to denote that just 1 hour of ischemia followed by 2 hours 
of reperfusion was enough to cause a significant decrease in fenes-
trae frequency and, therefore, reduced endothelial porosity without 
changes in fenestrae diameter. This detrimental effect of WIR was 
evident both in the sinusoidal endothelium of aged rats suffering 
acute liver injury in vivo, and in primary LSEC undergoing in vitro 
anoxia/reoxygenation. Interestingly, simvastatin administration be-
fore acute injury significantly prevented the deterioration in endo-
thelial phenotype maintaining fenestrae frequency and porosity in 
both experimental conditions. Altogether, our results suggest that the 
vasoprotective effects of simvastatin would not only maintain LSEC 
functionality but also promote a better exchange of molecules be-
tween blood and hepatocytes, hence indirectly improving the pheno-
type of the liver parenchyma.
Although different research groups have focused on the study 
of fenestrae formation and modulation, to date no clear mechanis-
tic description is universally accepted beyond the role of the cellular 
cytoskeleton in fenestrae dynamics (49). Consequently, we studied 
actin organization and part of its molecular mechanisms in LSEC 
isolated from aged animals showing a marked improvement in actin 
organization in response to simvastatin, which was accompanied by 
up-regulation in VEGF together with a negative feedback mechanism 
with its cellular receptor Flk-1. Another described mechanism impli-
cated in fenestrae diameter regulation involves the activation of Rho 
protein family (including RhoA and Rho-kinase) and further phos-
phorylation of myosin light chain and inhibition of its phosphatase 
(36). Nevertheless, analysis of p-MLC and p-moesin in liver tissues 
from the vehicle and simvastatin WIR groups did not show any dif-
ference. The full characterization of fenestrae dynamics was out of 
the scope of the present study but future desirable experiments will 
further characterize the role of the cytoskeleton in LSEC fenestrae.
While we have used an experimental model of WIR that prop-
erly mimics common clinical situations such as hypovolemic shock 
consequence of a major hemorrhage, or hepatic ischemia and rep-
erfusion occurring during the excision of small tumors, this model 
may not necessary extends to an accurate depiction of major hepatic 
resection post WIR. Future experiments analyzing the microcircula-
tory status at later reperfusion times may add important information 
to such clinical situations. Finally, it has to be noted that, although 
protective, the beneficial effects of statins in aged animals were less 
than those observed in young rats undergoing WIR (6). We can-
not discard a possible optimization of simvastatin beneficial effects 
in the clinical scenario of acute liver injury in aged individuals by 
extending the period of treatment, likely after liver surgery. Indeed, 
unpublished data from our group demonstrate that 2-week simvas-
tatin treatment improves chronic liver disease in aged animals (50). 
The limited results in old animals suggest that those individuals may 
require specific preclinical studies to develop safe and efficient treat-
ments to prevent acute liver injury.
In conclusion, our study, although descriptive in nature, is the 
first revealing that aged livers are prone to develop sinusoidal 
microcirculatory dysfunction in response to an acute insult, which 
ultimately contributes to global liver damage. Consequently, consid-
ering the median age of patients undergoing hepatic surgery and the 
results herein described, we propose that future studies focused on 
the development of treatments for acute liver injury in the setting 
of ischemia reperfusion injury should include older animal models.
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